Form D — Slate Medicines, Inc.
0001231919-26-000246 · filed Mar 11, 2026
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $130,000,000
- Total sold
- $9,999,992
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Slate Medicines, Inc.
- CIK
- 2117806
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2024
- Address
- 200 BERKELEY STREET, 18TH FLOOR
BOSTON, MA 02116 - Phone
- (617) 778-2500
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Andrew Levin · DirectorBoston, MA Find on LinkedIn ↗
-
Cindy Xiong · DirectorBoston, MA Find on LinkedIn ↗
-
Tim Lohoff · DirectorBoston, MA Find on LinkedIn ↗
-
Neil Buckley · Executive OfficerBoston, MA Find on LinkedIn ↗
-
Sara Pacheco · Executive OfficerBoston, MA Find on LinkedIn ↗
-
Gregory Frank Oakes · Executive OfficerBoston, MA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗